Welcome to AMRIX.com

The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.

Cancel
OK
AMRIX
  • Healthcare Professionals Home
  • Manage Acute Muscle Spasms
  • About Amrix
  • Convenient Once-Daily Dosing
  • Proven Efficacy
  • Safety
  • Physician Resources
Visit Patient Website

  • Resources For Your Patients
  • Frequently Asked Questions

Instant Savings Coupon for a $30 Copay Reduction
Free 2-Day Sample of AMRIX
Muscle Spasm and the Role of AMRIX - View Animation
Frequently Asked Questions - Learn More
Role of AMRIX in Treating Muscle Spasm - View Video
Small text
Medium text
Large text
Select Text Size
Send to a Colleague
Print Page
About AMRIX - AMRIX offers an effective and convenient solution for relief of acute muscle spasm.
AMRIX Proven Efficacy - Learn More
Extended-Release Formulation - Learn More
Low Somnolence - Learn More
Demonstrated Safety - AMRIX is generally well tolerated
Once-Daily Dose - Discover the benefits and convenience of once-daily dosing with AMRIX
Role of AMRIX in Treating Muscle Spasm - View Video

Physician Resources

Physician Resources

  • Resources for Your Patients
  • Frequently Asked Questions
  • Role of AMRIX in Treating Muscle Spasm - Video
Important Safety Information

AMRIX (Cyclobenzaprine Hydrochloride Extended-Release Capsules) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. AMRIX should be used only for short periods (up to two or three weeks). AMRIX has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease or in children with cerebral palsy.

AMRIX is contraindicated in patients who are hypersensitive to any of its components. AMRIX is contraindicated with concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation. AMRIX may have life-threatening interactions with MAO inhibitors. AMRIX is contraindicated during the acute recovery phase of myocardial infarction; in patients with arrhythmias, heart block conduction disturbances, or congestive heart failure; or in patients with hyperthyroidism. AMRIX may enhance the effects of alcohol, barbiturates, and other CNS depressants. AMRIX should not be used in elderly patients or in patients with impaired hepatic function.

AMRIX is closely related to tricyclic antidepressants, which have been reported to produce arrhythmias, sinus tachycardia, prolongation of the conduction time leading to myocardial infarction, and stroke.

Because of its atropine-like action, AMRIX should be used with caution in patients with a history of urinary retention, angle-closure glaucoma, increased intraocular pressure, and in patients taking anticholinergic medication. AMRIX, especially when used with alcohol or other CNS depressants, may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle.

In clinical trials, the most commonly reported adverse reactions (≥3%) with AMRIX were dry mouth, dizziness, fatigue, nausea, dyspepsia, and constipation.

The recommended adult dose of AMRIX for most patients is one (1) AMRIX 15-mg capsule taken once daily. Some patients may require up to 30 mg/day, given as one (1) AMRIX 30-mg capsule taken once daily or as two (2) AMRIX 15-mg capsules taken once daily. AMRIX should be taken at approximately the same time each day.

Please see accompanying full Prescribing Information.

-
Cephalon
Prescribing Information | Important Safety Information | References
Privacy Policy | Legal Notice | Contact Us | Cephalon.com | Site Map
©2010 Cephalon, Inc. All rights reserved. AMRIX  is produced with Eurand Diffucaps® technology.